IN8bio, Inc.

8-K Entered a material agreement; Terminated a material agreement Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Director or officer change; Shareholder vote results May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Director or officer change Feb 27, 2026 8-K Director or officer change Feb 9, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 19, 2025 8-K Other events Nov 24, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jun 30, 2025 8-K Modified rights of security holders Jun 4, 2025 8-K Other events Jun 2, 2025 8-K Shareholder vote results May 9, 2025 10-K/A Fiscal year ended 2024-12-31 May 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Other events Apr 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Director or officer change Mar 5, 2025 8-K Other events Mar 3, 2025 8-K Other events Feb 11, 2025 8-K Delisting notice or listing-rule failure; Item 5.08 Feb 7, 2025 8-K Other events Dec 10, 2024 8-K Other events Nov 25, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Oct 1, 2024 8-K Director or officer change Sep 11, 2024 8-K Director or officer change Sep 6, 2024 8-K Exit or disposal costs; Other events Sep 4, 2024 8-K Other events Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024